3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other
1
Head & Neck
1
Conditions
Breast Neoplasms
32
Neoplasms
26
Depression
21
Fatigue
20
Prostatic Neoplasms
13
Lymphoma, Follicular
12
Precursor Cell Lymphoblastic Leukemia-Lymphoma
11
Multiple Myeloma
11
Lymphoma, Large B-Cell, Diffuse
10
Lung Neoplasms
10
Colorectal Neoplasms
10
Carcinoma, Non-Small-Cell Lung
10
Pain
9
Lymphoma, Non-Hodgkin
9
Lymphoma, Mantle-Cell
9
Lymphoma, Large-Cell, Immunoblastic
9
Lymphoma, B-Cell, Marginal Zone
9
Leukemia, Myeloid, Chronic-Phase
9
Leukemia, Lymphocytic, Chronic, B-Cell
9
Hodgkin Disease
9
Burkitt Lymphoma
9
Anxiety Disorders
9
Vomiting
7
Nausea
7
Leukemia, Myeloid, Acute
7
Leukemia, Myeloid, Accelerated Phase
7
Leukemia, Hairy Cell
7
Head and Neck Neoplasms
7
Carcinoma, Ovarian Epithelial
7
Blast Crisis
7
Interventions
Radiotherapy
6
Fibroblast Growth Factor 7
4
Injections
3
Drug Therapy
3
Cisplatin
3
Water
2
Propolis
2
Mouthwashes
2
Morphine
2
Methotrexate
2
Melphalan
2
Low-Level Light Therapy
2
Interleukin 1 Receptor Antagonist Protein
2
Gabapentin
2
Cryotherapy
2
peppermint oil
1
pegaspargase
1
oxycodone-acetaminophen
1
nelarabine
1
kang-lai-te
1
glucarpidase
1
fludarabine phosphate
1
fish oil triglycerides
1
cyclohexaneacetic acid
1
calcium phosphate
1
brilacidin
1
anise oil
1
amlexanox
1
aluminum hydroxide, magnesium hydroxide, drug combination
1
acetaminophen, hydrocodone drug combination
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Mucositis
×
Therapeutics
×
Clear all
NCT04046250
2023-08-25
TK112690
Tosk, Inc.
Phase 2
Completed
22 enrolled
10 charts